Partnerships can transform the trajectory of a health-tech startup. Johanna Majamaa, CEO of GekkoVet discusses how working with Royal Canin enabled the company to validate its platform across 100 clinics, demonstrate real-world impact, and lay the groundwork for expansion into new markets and universities.

Securing the right exit is critical to ensuring innovation achieves full market potential. Louise Grubb, Managing Director of TriviumVet, shares how the company balanced growth milestones, resisted low valuations, and leveraged regulatory success to secure the right partner at the right time to achieve sustainable scale post-acquisition.